WHO WE ARE
Setup in 2004, the Multiple Sclerosis Trials Collaboration (MSTC) was created to facilitate access to treatments and research for people living with MS.
MSTC aims to provide patients with MS who are not suitable for current therapies, access to pharmaceutical-sponsored clinical trials. Furthermore, to use generated income by undertaking pharmaceutical clinical trials to devise and administer research-led clinical trials thereby providing greater access to potential treatments to more MS patients.
The trustees are practising clinicians treating people with MS. We administer currently available treatments in the UK and take part in interventional studies but want to develop better treatments.
We are keen to support work that improves the lives of people with MS through access to new treatments and approaches to treatment.
MSTC aims to provide patients with MS who are not suitable for current therapies, access to pharmaceutical-sponsored clinical trials. Furthermore, to use generated income by undertaking pharmaceutical clinical trials to devise and administer research-led clinical trials thereby providing greater access to potential treatments to more MS patients.
The trustees are practising clinicians treating people with MS. We administer currently available treatments in the UK and take part in interventional studies but want to develop better treatments.
We are keen to support work that improves the lives of people with MS through access to new treatments and approaches to treatment.